instruction stringlengths 34 186 | input stringlengths 2.02k 93.8k | output stringlengths 2 418 | meta_questiontype stringclasses 6
values | meta_inputlicense stringclasses 6
values | meta_pmid stringlengths 8 8 | meta_safetyreportid int64 9.51M 21M | meta_articlepubdate stringlengths 4 10 |
|---|---|---|---|---|---|---|---|
What was the administration route of drug 'TERIFLUNOMIDE'? | Ponesimod Compared With Teriflunomide in Patients With Relapsing Multiple Sclerosis in the Active-Comparator Phase 3 OPTIMUM Study: A Randomized Clinical Trial.
To our knowledge, the Oral Ponesimod Versus Teriflunomide In Relapsing Multiple Sclerosis (OPTIMUM) trial is the first phase 3 study comparing 2 oral disease-m... | Oral | DrugAdministrationRoute | CC BY-NC-ND | 33779698 | 19,140,213 | 2021-05-01 |
What was the outcome of reaction 'Epilepsy'? | Ponesimod Compared With Teriflunomide in Patients With Relapsing Multiple Sclerosis in the Active-Comparator Phase 3 OPTIMUM Study: A Randomized Clinical Trial.
To our knowledge, the Oral Ponesimod Versus Teriflunomide In Relapsing Multiple Sclerosis (OPTIMUM) trial is the first phase 3 study comparing 2 oral disease-m... | Not recovered | ReactionOutcome | CC BY-NC-ND | 33779698 | 19,140,213 | 2021-05-01 |
What was the outcome of reaction 'Generalised tonic-clonic seizure'? | Ponesimod Compared With Teriflunomide in Patients With Relapsing Multiple Sclerosis in the Active-Comparator Phase 3 OPTIMUM Study: A Randomized Clinical Trial.
To our knowledge, the Oral Ponesimod Versus Teriflunomide In Relapsing Multiple Sclerosis (OPTIMUM) trial is the first phase 3 study comparing 2 oral disease-m... | Recovered | ReactionOutcome | CC BY-NC-ND | 33779698 | 19,140,213 | 2021-05-01 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Cholelithiasis'. | Incident Gallstones During Somatostatin Analog Treatment are Associated with Acute Biliary Complications Especially After Discontinuation.
BACKGROUND
Gallstones are a known adverse effect of somatostatin analogs, but the exact incidence and clinical implications are unknown.
OBJECTIVE
The aim of this study was to inv... | LANREOTIDE ACETATE | DrugsGivenReaction | CC BY-NC | 33779943 | 19,203,557 | 2021-06 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Gastrointestinal haemorrhage'. | Incident Gallstones During Somatostatin Analog Treatment are Associated with Acute Biliary Complications Especially After Discontinuation.
BACKGROUND
Gallstones are a known adverse effect of somatostatin analogs, but the exact incidence and clinical implications are unknown.
OBJECTIVE
The aim of this study was to inv... | LANREOTIDE ACETATE | DrugsGivenReaction | CC BY-NC | 33779943 | 19,203,417 | 2021-06 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Multiple organ dysfunction syndrome'. | Incident Gallstones During Somatostatin Analog Treatment are Associated with Acute Biliary Complications Especially After Discontinuation.
BACKGROUND
Gallstones are a known adverse effect of somatostatin analogs, but the exact incidence and clinical implications are unknown.
OBJECTIVE
The aim of this study was to inv... | LANREOTIDE ACETATE | DrugsGivenReaction | CC BY-NC | 33779943 | 19,203,417 | 2021-06 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Obstructive pancreatitis'. | Incident Gallstones During Somatostatin Analog Treatment are Associated with Acute Biliary Complications Especially After Discontinuation.
BACKGROUND
Gallstones are a known adverse effect of somatostatin analogs, but the exact incidence and clinical implications are unknown.
OBJECTIVE
The aim of this study was to inv... | LANREOTIDE ACETATE | DrugsGivenReaction | CC BY-NC | 33779943 | 19,203,557 | 2021-06 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Pancreatic fistula'. | Incident Gallstones During Somatostatin Analog Treatment are Associated with Acute Biliary Complications Especially After Discontinuation.
BACKGROUND
Gallstones are a known adverse effect of somatostatin analogs, but the exact incidence and clinical implications are unknown.
OBJECTIVE
The aim of this study was to inv... | LANREOTIDE ACETATE | DrugsGivenReaction | CC BY-NC | 33779943 | 19,203,633 | 2021-06 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Pancreatitis necrotising'. | Incident Gallstones During Somatostatin Analog Treatment are Associated with Acute Biliary Complications Especially After Discontinuation.
BACKGROUND
Gallstones are a known adverse effect of somatostatin analogs, but the exact incidence and clinical implications are unknown.
OBJECTIVE
The aim of this study was to inv... | LANREOTIDE ACETATE | DrugsGivenReaction | CC BY-NC | 33779943 | 19,203,417 | 2021-06 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Pneumonia'. | Incident Gallstones During Somatostatin Analog Treatment are Associated with Acute Biliary Complications Especially After Discontinuation.
BACKGROUND
Gallstones are a known adverse effect of somatostatin analogs, but the exact incidence and clinical implications are unknown.
OBJECTIVE
The aim of this study was to inv... | LANREOTIDE ACETATE | DrugsGivenReaction | CC BY-NC | 33779943 | 19,203,633 | 2021-06 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Porcelain gallbladder'. | Incident Gallstones During Somatostatin Analog Treatment are Associated with Acute Biliary Complications Especially After Discontinuation.
BACKGROUND
Gallstones are a known adverse effect of somatostatin analogs, but the exact incidence and clinical implications are unknown.
OBJECTIVE
The aim of this study was to inv... | LANREOTIDE ACETATE | DrugsGivenReaction | CC BY-NC | 33779943 | 19,203,533 | 2021-06 |
What was the administration route of drug 'LANREOTIDE ACETATE'? | Incident Gallstones During Somatostatin Analog Treatment are Associated with Acute Biliary Complications Especially After Discontinuation.
BACKGROUND
Gallstones are a known adverse effect of somatostatin analogs, but the exact incidence and clinical implications are unknown.
OBJECTIVE
The aim of this study was to inv... | Subcutaneous | DrugAdministrationRoute | CC BY-NC | 33779943 | 19,203,557 | 2021-06 |
What was the administration route of drug 'CIPROFLOXACIN'? | Leclercia adecarboxylata Bacteremia without a Focus in a Non-Immunosuppressed Patient.
BACKGROUND Leclercia adecarboxylata is a gram-negative rod, which is normally found in water and food. It is an emerging pathogen that affects immunocompromised patients, including patients with hematological malignancies or those re... | Intravenous (not otherwise specified) | DrugAdministrationRoute | CC BY-NC-ND | 33782375 | 19,691,323 | 2021-03-30 |
What was the administration route of drug 'FUROSEMIDE'? | Leclercia adecarboxylata Bacteremia without a Focus in a Non-Immunosuppressed Patient.
BACKGROUND Leclercia adecarboxylata is a gram-negative rod, which is normally found in water and food. It is an emerging pathogen that affects immunocompromised patients, including patients with hematological malignancies or those re... | Intravenous (not otherwise specified) | DrugAdministrationRoute | CC BY-NC-ND | 33782375 | 19,691,323 | 2021-03-30 |
What was the administration route of drug 'METRONIDAZOLE'? | Leclercia adecarboxylata Bacteremia without a Focus in a Non-Immunosuppressed Patient.
BACKGROUND Leclercia adecarboxylata is a gram-negative rod, which is normally found in water and food. It is an emerging pathogen that affects immunocompromised patients, including patients with hematological malignancies or those re... | Intravenous (not otherwise specified) | DrugAdministrationRoute | CC BY-NC-ND | 33782375 | 19,645,053 | 2021-03-30 |
What was the administration route of drug 'VANCOMYCIN HYDROCHLORIDE'? | Leclercia adecarboxylata Bacteremia without a Focus in a Non-Immunosuppressed Patient.
BACKGROUND Leclercia adecarboxylata is a gram-negative rod, which is normally found in water and food. It is an emerging pathogen that affects immunocompromised patients, including patients with hematological malignancies or those re... | Oral | DrugAdministrationRoute | CC BY-NC-ND | 33782375 | 19,645,053 | 2021-03-30 |
What was the administration route of drug 'VANCOMYCIN'? | Leclercia adecarboxylata Bacteremia without a Focus in a Non-Immunosuppressed Patient.
BACKGROUND Leclercia adecarboxylata is a gram-negative rod, which is normally found in water and food. It is an emerging pathogen that affects immunocompromised patients, including patients with hematological malignancies or those re... | Oral | DrugAdministrationRoute | CC BY-NC-ND | 33782375 | 19,691,323 | 2021-03-30 |
What was the outcome of reaction 'Drug ineffective'? | Leclercia adecarboxylata Bacteremia without a Focus in a Non-Immunosuppressed Patient.
BACKGROUND Leclercia adecarboxylata is a gram-negative rod, which is normally found in water and food. It is an emerging pathogen that affects immunocompromised patients, including patients with hematological malignancies or those re... | Fatal | ReactionOutcome | CC BY-NC-ND | 33782375 | 19,645,053 | 2021-03-30 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Gastrointestinal perforation'. | Bevacizumab plus capecitabine as later-line treatment for patients with metastatic colorectal cancer refractory to irinotecan, oxaliplatin, and fluoropyrimidines.
There is an unmet medical need for later-line treatment options for patients with metastatic colorectal cancer (mCRC). Considering that, beyond progression, ... | BEVACIZUMAB, CAPECITABINE | DrugsGivenReaction | CC BY | 33782470 | 19,138,935 | 2021-03-29 |
What was the administration route of drug 'CAPECITABINE'? | Bevacizumab plus capecitabine as later-line treatment for patients with metastatic colorectal cancer refractory to irinotecan, oxaliplatin, and fluoropyrimidines.
There is an unmet medical need for later-line treatment options for patients with metastatic colorectal cancer (mCRC). Considering that, beyond progression, ... | Oral | DrugAdministrationRoute | CC BY | 33782470 | 19,138,935 | 2021-03-29 |
What was the dosage of drug 'BEVACIZUMAB'? | Bevacizumab plus capecitabine as later-line treatment for patients with metastatic colorectal cancer refractory to irinotecan, oxaliplatin, and fluoropyrimidines.
There is an unmet medical need for later-line treatment options for patients with metastatic colorectal cancer (mCRC). Considering that, beyond progression, ... | ON DAY 1 | DrugDosageText | CC BY | 33782470 | 19,138,935 | 2021-03-29 |
What was the dosage of drug 'CAPECITABINE'? | Bevacizumab plus capecitabine as later-line treatment for patients with metastatic colorectal cancer refractory to irinotecan, oxaliplatin, and fluoropyrimidines.
There is an unmet medical need for later-line treatment options for patients with metastatic colorectal cancer (mCRC). Considering that, beyond progression, ... | (PO) TWICE DAILY ON DAY 1 TO 14 | DrugDosageText | CC BY | 33782470 | 19,138,935 | 2021-03-29 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Acute coronary syndrome'. | Should beta-blockers be continued as a treatment for myocardial infarction in the case of Kounis syndrome?
A 71-year-old male patient reported to our hospital with anaphylactic shock, and the following two issues were focused in this case. First, he was resistant to adrenaline because of taking beta-blocker, and shock ... | AMLODIPINE BESYLATE, AZILSARTAN KAMEDOXOMIL, BISOPROLOL, DEXCHLORPHENIRAMINE MALEATE, EPINEPHRINE, FAMOTIDINE | DrugsGivenReaction | CC BY-NC | 33783917 | 19,217,800 | 2021-07 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Drug interaction'. | Should beta-blockers be continued as a treatment for myocardial infarction in the case of Kounis syndrome?
A 71-year-old male patient reported to our hospital with anaphylactic shock, and the following two issues were focused in this case. First, he was resistant to adrenaline because of taking beta-blocker, and shock ... | AMLODIPINE BESYLATE, AZILSARTAN KAMEDOXOMIL, BISOPROLOL, DEXCHLORPHENIRAMINE MALEATE, EPINEPHRINE, FAMOTIDINE | DrugsGivenReaction | CC BY-NC | 33783917 | 19,217,800 | 2021-07 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Drug resistance'. | Should beta-blockers be continued as a treatment for myocardial infarction in the case of Kounis syndrome?
A 71-year-old male patient reported to our hospital with anaphylactic shock, and the following two issues were focused in this case. First, he was resistant to adrenaline because of taking beta-blocker, and shock ... | AMLODIPINE BESYLATE, AZILSARTAN KAMEDOXOMIL, BISOPROLOL, DEXCHLORPHENIRAMINE MALEATE, EPINEPHRINE, FAMOTIDINE | DrugsGivenReaction | CC BY-NC | 33783917 | 19,217,800 | 2021-07 |
What was the administration route of drug 'AMLODIPINE BESYLATE'? | Should beta-blockers be continued as a treatment for myocardial infarction in the case of Kounis syndrome?
A 71-year-old male patient reported to our hospital with anaphylactic shock, and the following two issues were focused in this case. First, he was resistant to adrenaline because of taking beta-blocker, and shock ... | Oral | DrugAdministrationRoute | CC BY-NC | 33783917 | 19,157,817 | 2021-07 |
What was the administration route of drug 'AZILSARTAN KAMEDOXOMIL'? | Should beta-blockers be continued as a treatment for myocardial infarction in the case of Kounis syndrome?
A 71-year-old male patient reported to our hospital with anaphylactic shock, and the following two issues were focused in this case. First, he was resistant to adrenaline because of taking beta-blocker, and shock ... | Oral | DrugAdministrationRoute | CC BY-NC | 33783917 | 19,157,817 | 2021-07 |
What was the administration route of drug 'BISOPROLOL'? | Should beta-blockers be continued as a treatment for myocardial infarction in the case of Kounis syndrome?
A 71-year-old male patient reported to our hospital with anaphylactic shock, and the following two issues were focused in this case. First, he was resistant to adrenaline because of taking beta-blocker, and shock ... | Oral | DrugAdministrationRoute | CC BY-NC | 33783917 | 19,157,817 | 2021-07 |
What was the administration route of drug 'DEXCHLORPHENIRAMINE MALEATE'? | Should beta-blockers be continued as a treatment for myocardial infarction in the case of Kounis syndrome?
A 71-year-old male patient reported to our hospital with anaphylactic shock, and the following two issues were focused in this case. First, he was resistant to adrenaline because of taking beta-blocker, and shock ... | Intravenous (not otherwise specified) | DrugAdministrationRoute | CC BY-NC | 33783917 | 19,157,817 | 2021-07 |
What was the administration route of drug 'EPINEPHRINE'? | Should beta-blockers be continued as a treatment for myocardial infarction in the case of Kounis syndrome?
A 71-year-old male patient reported to our hospital with anaphylactic shock, and the following two issues were focused in this case. First, he was resistant to adrenaline because of taking beta-blocker, and shock ... | Intramuscular | DrugAdministrationRoute | CC BY-NC | 33783917 | 19,157,817 | 2021-07 |
What was the administration route of drug 'FAMOTIDINE'? | Should beta-blockers be continued as a treatment for myocardial infarction in the case of Kounis syndrome?
A 71-year-old male patient reported to our hospital with anaphylactic shock, and the following two issues were focused in this case. First, he was resistant to adrenaline because of taking beta-blocker, and shock ... | Intravenous (not otherwise specified) | DrugAdministrationRoute | CC BY-NC | 33783917 | 19,157,817 | 2021-07 |
What was the administration route of drug 'HYDROCORTISONE SODIUM SUCCINATE'? | Should beta-blockers be continued as a treatment for myocardial infarction in the case of Kounis syndrome?
A 71-year-old male patient reported to our hospital with anaphylactic shock, and the following two issues were focused in this case. First, he was resistant to adrenaline because of taking beta-blocker, and shock ... | Intravenous (not otherwise specified) | DrugAdministrationRoute | CC BY-NC | 33783917 | 19,157,817 | 2021-07 |
What was the dosage of drug 'AMLODIPINE BESYLATE'? | Should beta-blockers be continued as a treatment for myocardial infarction in the case of Kounis syndrome?
A 71-year-old male patient reported to our hospital with anaphylactic shock, and the following two issues were focused in this case. First, he was resistant to adrenaline because of taking beta-blocker, and shock ... | 10 mg (milligrams). | DrugDosage | CC BY-NC | 33783917 | 19,217,800 | 2021-07 |
What was the dosage of drug 'AZILSARTAN KAMEDOXOMIL'? | Should beta-blockers be continued as a treatment for myocardial infarction in the case of Kounis syndrome?
A 71-year-old male patient reported to our hospital with anaphylactic shock, and the following two issues were focused in this case. First, he was resistant to adrenaline because of taking beta-blocker, and shock ... | 40 mg (milligrams). | DrugDosage | CC BY-NC | 33783917 | 19,217,800 | 2021-07 |
What was the dosage of drug 'BISOPROLOL'? | Should beta-blockers be continued as a treatment for myocardial infarction in the case of Kounis syndrome?
A 71-year-old male patient reported to our hospital with anaphylactic shock, and the following two issues were focused in this case. First, he was resistant to adrenaline because of taking beta-blocker, and shock ... | 2.5 mg (milligrams). | DrugDosage | CC BY-NC | 33783917 | 19,217,800 | 2021-07 |
What was the outcome of reaction 'Kounis syndrome'? | Should beta-blockers be continued as a treatment for myocardial infarction in the case of Kounis syndrome?
A 71-year-old male patient reported to our hospital with anaphylactic shock, and the following two issues were focused in this case. First, he was resistant to adrenaline because of taking beta-blocker, and shock ... | Recovered | ReactionOutcome | CC BY-NC | 33783917 | 19,157,817 | 2021-07 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Appendicitis'. | Two cases of lung cancer with hemophagocytic lymphohistiocytosis caused by immune checkpoint inhibitors.
We report the cases of two patients with secondary hemophagocytic lymphohistiocytosis caused by immune checkpoint inhibitors, who were diagnosed using the recently developed HScore. The first patient presented with ... | CARBOPLATIN, PEMBROLIZUMAB, PEMETREXED DISODIUM | DrugsGivenReaction | CC BY | 33783978 | 18,451,510 | 2021-05 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Disseminated intravascular coagulation'. | Two cases of lung cancer with hemophagocytic lymphohistiocytosis caused by immune checkpoint inhibitors.
We report the cases of two patients with secondary hemophagocytic lymphohistiocytosis caused by immune checkpoint inhibitors, who were diagnosed using the recently developed HScore. The first patient presented with ... | CARBOPLATIN, PEMBROLIZUMAB, PEMETREXED DISODIUM | DrugsGivenReaction | CC BY | 33783978 | 18,451,510 | 2021-05 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Haemophagocytic lymphohistiocytosis'. | Two cases of lung cancer with hemophagocytic lymphohistiocytosis caused by immune checkpoint inhibitors.
We report the cases of two patients with secondary hemophagocytic lymphohistiocytosis caused by immune checkpoint inhibitors, who were diagnosed using the recently developed HScore. The first patient presented with ... | CARBOPLATIN, PEMBROLIZUMAB, PEMETREXED DISODIUM | DrugsGivenReaction | CC BY | 33783978 | 18,451,510 | 2021-05 |
What is the weight of the patient? | Two cases of lung cancer with hemophagocytic lymphohistiocytosis caused by immune checkpoint inhibitors.
We report the cases of two patients with secondary hemophagocytic lymphohistiocytosis caused by immune checkpoint inhibitors, who were diagnosed using the recently developed HScore. The first patient presented with ... | 46 kg. | Weight | CC BY | 33783978 | 18,451,510 | 2021-05 |
What was the administration route of drug 'CARBOPLATIN'? | Two cases of lung cancer with hemophagocytic lymphohistiocytosis caused by immune checkpoint inhibitors.
We report the cases of two patients with secondary hemophagocytic lymphohistiocytosis caused by immune checkpoint inhibitors, who were diagnosed using the recently developed HScore. The first patient presented with ... | Intravenous (not otherwise specified) | DrugAdministrationRoute | CC BY | 33783978 | 18,451,510 | 2021-05 |
What was the administration route of drug 'PEMBROLIZUMAB'? | Two cases of lung cancer with hemophagocytic lymphohistiocytosis caused by immune checkpoint inhibitors.
We report the cases of two patients with secondary hemophagocytic lymphohistiocytosis caused by immune checkpoint inhibitors, who were diagnosed using the recently developed HScore. The first patient presented with ... | Intravenous drip | DrugAdministrationRoute | CC BY | 33783978 | 18,451,510 | 2021-05 |
What was the administration route of drug 'PEMETREXED DISODIUM'? | Two cases of lung cancer with hemophagocytic lymphohistiocytosis caused by immune checkpoint inhibitors.
We report the cases of two patients with secondary hemophagocytic lymphohistiocytosis caused by immune checkpoint inhibitors, who were diagnosed using the recently developed HScore. The first patient presented with ... | Intravenous (not otherwise specified) | DrugAdministrationRoute | CC BY | 33783978 | 18,451,510 | 2021-05 |
What was the dosage of drug 'CARBOPLATIN'? | Two cases of lung cancer with hemophagocytic lymphohistiocytosis caused by immune checkpoint inhibitors.
We report the cases of two patients with secondary hemophagocytic lymphohistiocytosis caused by immune checkpoint inhibitors, who were diagnosed using the recently developed HScore. The first patient presented with ... | UNK, Q3W | DrugDosageText | CC BY | 33783978 | 18,451,510 | 2021-05 |
What was the dosage of drug 'PEMETREXED DISODIUM'? | Two cases of lung cancer with hemophagocytic lymphohistiocytosis caused by immune checkpoint inhibitors.
We report the cases of two patients with secondary hemophagocytic lymphohistiocytosis caused by immune checkpoint inhibitors, who were diagnosed using the recently developed HScore. The first patient presented with ... | UNK, Q3W | DrugDosageText | CC BY | 33783978 | 18,451,510 | 2021-05 |
What was the outcome of reaction 'Haemophagocytic lymphohistiocytosis'? | Two cases of lung cancer with hemophagocytic lymphohistiocytosis caused by immune checkpoint inhibitors.
We report the cases of two patients with secondary hemophagocytic lymphohistiocytosis caused by immune checkpoint inhibitors, who were diagnosed using the recently developed HScore. The first patient presented with ... | Recovered | ReactionOutcome | CC BY | 33783978 | 18,451,510 | 2021-05 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Blast cell count decreased'. | Mixed phenotype acute leukemia in a child associated with a NUP98-NSD1 fusion and NRAS p.Gly61Arg mutation.
Mixed phenotype acute leukemia (MPAL) is a rare subset of acute leukemia in the pediatric population associated with genetic alterations seen in both acute lymphoblastic leukemia (ALL) and acute myeloid leukemia ... | AZACITIDINE, BUSULFAN, CYTARABINE, DAUNORUBICIN, FLUDARABINE PHOSPHATE, GRANULOCYTE COLONY-STIMULATING FACTOR NOS, MYCOPHENOLATE MOFETIL, SIROLIMUS, TACROLIMUS, THYMOCYTE IMMUNE GLOBULIN NOS | DrugsGivenReaction | CC BY | 33784031 | 20,646,228 | 2021-08 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Graft versus host disease in skin'. | Mixed phenotype acute leukemia in a child associated with a NUP98-NSD1 fusion and NRAS p.Gly61Arg mutation.
Mixed phenotype acute leukemia (MPAL) is a rare subset of acute leukemia in the pediatric population associated with genetic alterations seen in both acute lymphoblastic leukemia (ALL) and acute myeloid leukemia ... | AZACITIDINE, BUSULFAN, FLUDARABINE PHOSPHATE, MYCOPHENOLATE MOFETIL, SIROLIMUS, TACROLIMUS, THYMOCYTE IMMUNE GLOBULIN NOS | DrugsGivenReaction | CC BY | 33784031 | 20,634,154 | 2021-08 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'White blood cell count decreased'. | Mixed phenotype acute leukemia in a child associated with a NUP98-NSD1 fusion and NRAS p.Gly61Arg mutation.
Mixed phenotype acute leukemia (MPAL) is a rare subset of acute leukemia in the pediatric population associated with genetic alterations seen in both acute lymphoblastic leukemia (ALL) and acute myeloid leukemia ... | AZACITIDINE, BUSULFAN, CYTARABINE, DAUNORUBICIN, FLUDARABINE PHOSPHATE, GRANULOCYTE COLONY-STIMULATING FACTOR NOS, MYCOPHENOLATE MOFETIL, SIROLIMUS, TACROLIMUS, THYMOCYTE IMMUNE GLOBULIN NOS | DrugsGivenReaction | CC BY | 33784031 | 20,646,228 | 2021-08 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Anaphylactic reaction'. | Clinical dilemma of management: Cardiac arrest after microsclerotherapy for lower limb telangiectasia with liquid 0.3% aethoxysklerol or idiopathic cardiac arrest?
A 48-year-old woman attended to discuss a dilemma. She had suffered a cardiac arrest immediately following microsclerotherapy of leg telangiectasia with 0.3... | ACETAMINOPHEN | DrugsGivenReaction | CC BY-NC | 33786187 | 19,130,580 | 2021 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Cardiac arrest'. | Clinical dilemma of management: Cardiac arrest after microsclerotherapy for lower limb telangiectasia with liquid 0.3% aethoxysklerol or idiopathic cardiac arrest?
A 48-year-old woman attended to discuss a dilemma. She had suffered a cardiac arrest immediately following microsclerotherapy of leg telangiectasia with 0.3... | POLIDOCANOL | DrugsGivenReaction | CC BY-NC | 33786187 | 19,094,136 | 2021 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Circulatory collapse'. | Clinical dilemma of management: Cardiac arrest after microsclerotherapy for lower limb telangiectasia with liquid 0.3% aethoxysklerol or idiopathic cardiac arrest?
A 48-year-old woman attended to discuss a dilemma. She had suffered a cardiac arrest immediately following microsclerotherapy of leg telangiectasia with 0.3... | POLIDOCANOL | DrugsGivenReaction | CC BY-NC | 33786187 | 19,094,136 | 2021 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Dizziness'. | Clinical dilemma of management: Cardiac arrest after microsclerotherapy for lower limb telangiectasia with liquid 0.3% aethoxysklerol or idiopathic cardiac arrest?
A 48-year-old woman attended to discuss a dilemma. She had suffered a cardiac arrest immediately following microsclerotherapy of leg telangiectasia with 0.3... | POLIDOCANOL | DrugsGivenReaction | CC BY-NC | 33786187 | 19,094,136 | 2021 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Feeling abnormal'. | Clinical dilemma of management: Cardiac arrest after microsclerotherapy for lower limb telangiectasia with liquid 0.3% aethoxysklerol or idiopathic cardiac arrest?
A 48-year-old woman attended to discuss a dilemma. She had suffered a cardiac arrest immediately following microsclerotherapy of leg telangiectasia with 0.3... | POLIDOCANOL | DrugsGivenReaction | CC BY-NC | 33786187 | 19,094,136 | 2021 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Feeling hot'. | Clinical dilemma of management: Cardiac arrest after microsclerotherapy for lower limb telangiectasia with liquid 0.3% aethoxysklerol or idiopathic cardiac arrest?
A 48-year-old woman attended to discuss a dilemma. She had suffered a cardiac arrest immediately following microsclerotherapy of leg telangiectasia with 0.3... | POLIDOCANOL | DrugsGivenReaction | CC BY-NC | 33786187 | 19,094,136 | 2021 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Rash'. | Clinical dilemma of management: Cardiac arrest after microsclerotherapy for lower limb telangiectasia with liquid 0.3% aethoxysklerol or idiopathic cardiac arrest?
A 48-year-old woman attended to discuss a dilemma. She had suffered a cardiac arrest immediately following microsclerotherapy of leg telangiectasia with 0.3... | POLIDOCANOL | DrugsGivenReaction | CC BY-NC | 33786187 | 19,094,136 | 2021 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Swelling face'. | Clinical dilemma of management: Cardiac arrest after microsclerotherapy for lower limb telangiectasia with liquid 0.3% aethoxysklerol or idiopathic cardiac arrest?
A 48-year-old woman attended to discuss a dilemma. She had suffered a cardiac arrest immediately following microsclerotherapy of leg telangiectasia with 0.3... | POLIDOCANOL | DrugsGivenReaction | CC BY-NC | 33786187 | 19,094,136 | 2021 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Swelling of eyelid'. | Clinical dilemma of management: Cardiac arrest after microsclerotherapy for lower limb telangiectasia with liquid 0.3% aethoxysklerol or idiopathic cardiac arrest?
A 48-year-old woman attended to discuss a dilemma. She had suffered a cardiac arrest immediately following microsclerotherapy of leg telangiectasia with 0.3... | POLIDOCANOL | DrugsGivenReaction | CC BY-NC | 33786187 | 19,094,136 | 2021 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Ventricular fibrillation'. | Clinical dilemma of management: Cardiac arrest after microsclerotherapy for lower limb telangiectasia with liquid 0.3% aethoxysklerol or idiopathic cardiac arrest?
A 48-year-old woman attended to discuss a dilemma. She had suffered a cardiac arrest immediately following microsclerotherapy of leg telangiectasia with 0.3... | POLIDOCANOL | DrugsGivenReaction | CC BY-NC | 33786187 | 19,094,136 | 2021 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Vomiting'. | Clinical dilemma of management: Cardiac arrest after microsclerotherapy for lower limb telangiectasia with liquid 0.3% aethoxysklerol or idiopathic cardiac arrest?
A 48-year-old woman attended to discuss a dilemma. She had suffered a cardiac arrest immediately following microsclerotherapy of leg telangiectasia with 0.3... | MORPHINE SULFATE | DrugsGivenReaction | CC BY-NC | 33786187 | 19,474,935 | 2021 |
What was the outcome of reaction 'Rash'? | Clinical dilemma of management: Cardiac arrest after microsclerotherapy for lower limb telangiectasia with liquid 0.3% aethoxysklerol or idiopathic cardiac arrest?
A 48-year-old woman attended to discuss a dilemma. She had suffered a cardiac arrest immediately following microsclerotherapy of leg telangiectasia with 0.3... | Recovered | ReactionOutcome | CC BY-NC | 33786187 | 19,094,136 | 2021 |
What was the outcome of reaction 'Swelling face'? | Clinical dilemma of management: Cardiac arrest after microsclerotherapy for lower limb telangiectasia with liquid 0.3% aethoxysklerol or idiopathic cardiac arrest?
A 48-year-old woman attended to discuss a dilemma. She had suffered a cardiac arrest immediately following microsclerotherapy of leg telangiectasia with 0.3... | Recovered | ReactionOutcome | CC BY-NC | 33786187 | 19,094,136 | 2021 |
What was the outcome of reaction 'Swelling of eyelid'? | Clinical dilemma of management: Cardiac arrest after microsclerotherapy for lower limb telangiectasia with liquid 0.3% aethoxysklerol or idiopathic cardiac arrest?
A 48-year-old woman attended to discuss a dilemma. She had suffered a cardiac arrest immediately following microsclerotherapy of leg telangiectasia with 0.3... | Recovered | ReactionOutcome | CC BY-NC | 33786187 | 19,094,136 | 2021 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Hypercalcaemia'. | Negative cerebrospinal fluid β-d-glucan levels as an indicator for treatment cessation ahead of biochemical resolution: A case report of Candida glabrata meningitis.
Candida infections of the central nervous system (CNS) are rare. We report a case of Candida glabrata meningitis successfully treated with combination ant... | FLUCONAZOLE | DrugsGivenReaction | CC BY-NC-ND | 33786294 | 19,151,205 | 2021-06 |
What was the outcome of reaction 'Hypercalcaemia'? | Negative cerebrospinal fluid β-d-glucan levels as an indicator for treatment cessation ahead of biochemical resolution: A case report of Candida glabrata meningitis.
Candida infections of the central nervous system (CNS) are rare. We report a case of Candida glabrata meningitis successfully treated with combination ant... | Recovered | ReactionOutcome | CC BY-NC-ND | 33786294 | 19,151,205 | 2021-06 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Atrioventricular block complete'. | Immunotherapy-associated complete heart block in a patient with NSCLC: A case report and literature review.
The role for PD-1/PD-L1 and CTLA-4 targeted immunotherapy is well outlined in the treatment of metastatic NSCLC. Increased survival benefit supports the use of these medications and the development of next-genera... | IPILIMUMAB, NIVOLUMAB | DrugsGivenReaction | CC BY-NC-ND | 33786301 | 19,127,010 | 2021 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Cardiac failure'. | A novel scoring system to estimate chemotherapy-induced myocardial toxicity: Risk assessment prior to non-anthracycline chemotherapy regimens.
Myocardial toxicity is a common side effect of chemotherapy and is associated with adverse outcomes in cancer patients. Sufficient prediction of chemotherapy-induced myocardioto... | DENOSUMAB, PANITUMUMAB, TRASTUZUMAB | DrugsGivenReaction | CC BY-NC-ND | 33786364 | 19,093,061 | 2021-04 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Coronary artery disease'. | A novel scoring system to estimate chemotherapy-induced myocardial toxicity: Risk assessment prior to non-anthracycline chemotherapy regimens.
Myocardial toxicity is a common side effect of chemotherapy and is associated with adverse outcomes in cancer patients. Sufficient prediction of chemotherapy-induced myocardioto... | DENOSUMAB, PANITUMUMAB, TRASTUZUMAB | DrugsGivenReaction | CC BY-NC-ND | 33786364 | 19,093,061 | 2021-04 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Death'. | A novel scoring system to estimate chemotherapy-induced myocardial toxicity: Risk assessment prior to non-anthracycline chemotherapy regimens.
Myocardial toxicity is a common side effect of chemotherapy and is associated with adverse outcomes in cancer patients. Sufficient prediction of chemotherapy-induced myocardioto... | DENOSUMAB, PANITUMUMAB, TRASTUZUMAB | DrugsGivenReaction | CC BY-NC-ND | 33786364 | 19,093,061 | 2021-04 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Malignant neoplasm progression'. | A novel scoring system to estimate chemotherapy-induced myocardial toxicity: Risk assessment prior to non-anthracycline chemotherapy regimens.
Myocardial toxicity is a common side effect of chemotherapy and is associated with adverse outcomes in cancer patients. Sufficient prediction of chemotherapy-induced myocardioto... | DENOSUMAB, PANITUMUMAB, TRASTUZUMAB | DrugsGivenReaction | CC BY-NC-ND | 33786364 | 19,093,061 | 2021-04 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Multiple organ dysfunction syndrome'. | A novel scoring system to estimate chemotherapy-induced myocardial toxicity: Risk assessment prior to non-anthracycline chemotherapy regimens.
Myocardial toxicity is a common side effect of chemotherapy and is associated with adverse outcomes in cancer patients. Sufficient prediction of chemotherapy-induced myocardioto... | DENOSUMAB, PANITUMUMAB, TRASTUZUMAB | DrugsGivenReaction | CC BY-NC-ND | 33786364 | 19,093,061 | 2021-04 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Myocarditis'. | A novel scoring system to estimate chemotherapy-induced myocardial toxicity: Risk assessment prior to non-anthracycline chemotherapy regimens.
Myocardial toxicity is a common side effect of chemotherapy and is associated with adverse outcomes in cancer patients. Sufficient prediction of chemotherapy-induced myocardioto... | DENOSUMAB, PANITUMUMAB, TRASTUZUMAB | DrugsGivenReaction | CC BY-NC-ND | 33786364 | 19,093,061 | 2021-04 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Peripheral arterial occlusive disease'. | A novel scoring system to estimate chemotherapy-induced myocardial toxicity: Risk assessment prior to non-anthracycline chemotherapy regimens.
Myocardial toxicity is a common side effect of chemotherapy and is associated with adverse outcomes in cancer patients. Sufficient prediction of chemotherapy-induced myocardioto... | DENOSUMAB, PANITUMUMAB, TRASTUZUMAB | DrugsGivenReaction | CC BY-NC-ND | 33786364 | 19,093,061 | 2021-04 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Septic shock'. | A novel scoring system to estimate chemotherapy-induced myocardial toxicity: Risk assessment prior to non-anthracycline chemotherapy regimens.
Myocardial toxicity is a common side effect of chemotherapy and is associated with adverse outcomes in cancer patients. Sufficient prediction of chemotherapy-induced myocardioto... | DENOSUMAB, PANITUMUMAB, TRASTUZUMAB | DrugsGivenReaction | CC BY-NC-ND | 33786364 | 19,093,061 | 2021-04 |
What was the outcome of reaction 'Cardiac failure'? | A novel scoring system to estimate chemotherapy-induced myocardial toxicity: Risk assessment prior to non-anthracycline chemotherapy regimens.
Myocardial toxicity is a common side effect of chemotherapy and is associated with adverse outcomes in cancer patients. Sufficient prediction of chemotherapy-induced myocardioto... | Fatal | ReactionOutcome | CC BY-NC-ND | 33786364 | 19,093,061 | 2021-04 |
What was the outcome of reaction 'Death'? | A novel scoring system to estimate chemotherapy-induced myocardial toxicity: Risk assessment prior to non-anthracycline chemotherapy regimens.
Myocardial toxicity is a common side effect of chemotherapy and is associated with adverse outcomes in cancer patients. Sufficient prediction of chemotherapy-induced myocardioto... | Fatal | ReactionOutcome | CC BY-NC-ND | 33786364 | 19,093,061 | 2021-04 |
What was the outcome of reaction 'Malignant neoplasm progression'? | A novel scoring system to estimate chemotherapy-induced myocardial toxicity: Risk assessment prior to non-anthracycline chemotherapy regimens.
Myocardial toxicity is a common side effect of chemotherapy and is associated with adverse outcomes in cancer patients. Sufficient prediction of chemotherapy-induced myocardioto... | Fatal | ReactionOutcome | CC BY-NC-ND | 33786364 | 19,093,061 | 2021-04 |
What was the outcome of reaction 'Multiple organ dysfunction syndrome'? | A novel scoring system to estimate chemotherapy-induced myocardial toxicity: Risk assessment prior to non-anthracycline chemotherapy regimens.
Myocardial toxicity is a common side effect of chemotherapy and is associated with adverse outcomes in cancer patients. Sufficient prediction of chemotherapy-induced myocardioto... | Fatal | ReactionOutcome | CC BY-NC-ND | 33786364 | 19,093,061 | 2021-04 |
What was the outcome of reaction 'Septic shock'? | A novel scoring system to estimate chemotherapy-induced myocardial toxicity: Risk assessment prior to non-anthracycline chemotherapy regimens.
Myocardial toxicity is a common side effect of chemotherapy and is associated with adverse outcomes in cancer patients. Sufficient prediction of chemotherapy-induced myocardioto... | Fatal | ReactionOutcome | CC BY-NC-ND | 33786364 | 19,093,061 | 2021-04 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Off label use'. | COVID 19 infection in young patient with pectus excavatum
The SARS-Cov-2 infection causing the COVID 19 disease mainly affects the respiratory system, in most cases presenting mild symptoms, however in patients with comorbidities such as pectus excavatum that cause an alteration in lung function, the disease It can be ... | ACETAMINOPHEN, AMPICILLIN SODIUM\SULBACTAM SODIUM, AZITHROMYCIN ANHYDROUS, HEPARIN SODIUM, HYDROXYCHLOROQUINE, LOPINAVIR\RITONAVIR, OMEPRAZOLE, OSELTAMIVIR, OXYGEN, TIOTROPIUM | DrugsGivenReaction | CC BY-NC | 33787023 | 19,478,092 | 2021-03-25 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Hepatocellular carcinoma'. | Hyperprogression in a Patient With Hepatocellular Cancer Treated With Atezolizumab and Bevacizumab: A Case Report and Review of Literature.
Immune checkpoint inhibitors have emerged as a novel treatment in a wide variety of malignancies; however, it is associated with a distinctive array of side effects known as immune... | ATEZOLIZUMAB, BEVACIZUMAB | DrugsGivenReaction | CC BY-NC | 33787380 | 19,119,954 | 2021 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Off label use'. | Hyperprogression in a Patient With Hepatocellular Cancer Treated With Atezolizumab and Bevacizumab: A Case Report and Review of Literature.
Immune checkpoint inhibitors have emerged as a novel treatment in a wide variety of malignancies; however, it is associated with a distinctive array of side effects known as immune... | ATEZOLIZUMAB, BEVACIZUMAB | DrugsGivenReaction | CC BY-NC | 33787380 | 19,119,954 | 2021 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Myelofibrosis'. | Acute promyelocytic leukemia with myelofibrosis: A case report and literature review.
BACKGROUND
Acute promyelocytic leukemia (APL) with myelofibrosis (MF) is rare, and only 14 cases have been reported in the literature to date.
A 42-year-old woman was admitted to the hospital with easy bruising and excessive bleeding.... | ARSENIC TRIOXIDE, CYTARABINE, DAUNORUBICIN, HERBALS, IDARUBICIN, TRETINOIN | DrugsGivenReaction | CC BY | 33787572 | 19,197,011 | 2021-04-02 |
What was the administration route of drug 'ARSENIC TRIOXIDE'? | Acute promyelocytic leukemia with myelofibrosis: A case report and literature review.
BACKGROUND
Acute promyelocytic leukemia (APL) with myelofibrosis (MF) is rare, and only 14 cases have been reported in the literature to date.
A 42-year-old woman was admitted to the hospital with easy bruising and excessive bleeding.... | Intravenous (not otherwise specified) | DrugAdministrationRoute | CC BY | 33787572 | 19,197,011 | 2021-04-02 |
What was the administration route of drug 'DAUNORUBICIN'? | Acute promyelocytic leukemia with myelofibrosis: A case report and literature review.
BACKGROUND
Acute promyelocytic leukemia (APL) with myelofibrosis (MF) is rare, and only 14 cases have been reported in the literature to date.
A 42-year-old woman was admitted to the hospital with easy bruising and excessive bleeding.... | Intravenous (not otherwise specified) | DrugAdministrationRoute | CC BY | 33787572 | 19,197,011 | 2021-04-02 |
What was the administration route of drug 'HERBALS'? | Acute promyelocytic leukemia with myelofibrosis: A case report and literature review.
BACKGROUND
Acute promyelocytic leukemia (APL) with myelofibrosis (MF) is rare, and only 14 cases have been reported in the literature to date.
A 42-year-old woman was admitted to the hospital with easy bruising and excessive bleeding.... | Oral | DrugAdministrationRoute | CC BY | 33787572 | 19,197,011 | 2021-04-02 |
What was the administration route of drug 'TRETINOIN'? | Acute promyelocytic leukemia with myelofibrosis: A case report and literature review.
BACKGROUND
Acute promyelocytic leukemia (APL) with myelofibrosis (MF) is rare, and only 14 cases have been reported in the literature to date.
A 42-year-old woman was admitted to the hospital with easy bruising and excessive bleeding.... | Oral | DrugAdministrationRoute | CC BY | 33787572 | 19,197,011 | 2021-04-02 |
What was the dosage of drug 'CYTARABINE'? | Acute promyelocytic leukemia with myelofibrosis: A case report and literature review.
BACKGROUND
Acute promyelocytic leukemia (APL) with myelofibrosis (MF) is rare, and only 14 cases have been reported in the literature to date.
A 42-year-old woman was admitted to the hospital with easy bruising and excessive bleeding.... | 100 MG/M2 ON DAYS 1?6 | DrugDosageText | CC BY | 33787572 | 19,197,011 | 2021-04-02 |
What was the dosage of drug 'DAUNORUBICIN'? | Acute promyelocytic leukemia with myelofibrosis: A case report and literature review.
BACKGROUND
Acute promyelocytic leukemia (APL) with myelofibrosis (MF) is rare, and only 14 cases have been reported in the literature to date.
A 42-year-old woman was admitted to the hospital with easy bruising and excessive bleeding.... | 40 MG/M2 DAYS 6?8 | DrugDosageText | CC BY | 33787572 | 19,197,011 | 2021-04-02 |
What was the outcome of reaction 'Myelofibrosis'? | Acute promyelocytic leukemia with myelofibrosis: A case report and literature review.
BACKGROUND
Acute promyelocytic leukemia (APL) with myelofibrosis (MF) is rare, and only 14 cases have been reported in the literature to date.
A 42-year-old woman was admitted to the hospital with easy bruising and excessive bleeding.... | Recovered | ReactionOutcome | CC BY | 33787572 | 19,197,011 | 2021-04-02 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Hyperglycaemia'. | Clinical experience with biologic treatment in resistant eosinophilic fasciitis: Case reports and review of the literature.
BACKGROUND
Eosinophilic fasciitis (EF) is an uncommon connective tissue disorder characterized by limb and trunk erythema, with symmetrical thickening of the skin. Its pathogenesis is poorly under... | ALBENDAZOLE, METHOTREXATE, PREDNISONE | DrugsGivenReaction | CC BY | 33787639 | 19,594,825 | 2021-04-02 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Vomiting'. | Clinical experience with biologic treatment in resistant eosinophilic fasciitis: Case reports and review of the literature.
BACKGROUND
Eosinophilic fasciitis (EF) is an uncommon connective tissue disorder characterized by limb and trunk erythema, with symmetrical thickening of the skin. Its pathogenesis is poorly under... | METHOTREXATE, PREDNISONE | DrugsGivenReaction | CC BY | 33787639 | 19,591,409 | 2021-04-02 |
What was the outcome of reaction 'Drug dependence'? | Clinical experience with biologic treatment in resistant eosinophilic fasciitis: Case reports and review of the literature.
BACKGROUND
Eosinophilic fasciitis (EF) is an uncommon connective tissue disorder characterized by limb and trunk erythema, with symmetrical thickening of the skin. Its pathogenesis is poorly under... | Recovered | ReactionOutcome | CC BY | 33787639 | 19,591,409 | 2021-04-02 |
What was the dosage of drug 'CEFTRIAXONE'? | Aerococcus spp infective endocarditis following a prostate biopsy: a case report.
We report a rare case of an infective endocarditis by Aerococcus spp in a bioprosthetic aortic valve following a prostate biopsy, in an asymptomatic adult with no additional risk factor for prostate cancer, excepting for age. The diagnosi... | 2 g (grams). | DrugDosage | CC BY-NC | 33787738 | 19,222,161 | 2021 |
What was the dosage of drug 'GENTAMICIN'? | Aerococcus spp infective endocarditis following a prostate biopsy: a case report.
We report a rare case of an infective endocarditis by Aerococcus spp in a bioprosthetic aortic valve following a prostate biopsy, in an asymptomatic adult with no additional risk factor for prostate cancer, excepting for age. The diagnosi... | 60 mg (milligrams). | DrugDosage | CC BY-NC | 33787738 | 19,222,161 | 2021 |
What was the outcome of reaction 'Acute kidney injury'? | Aerococcus spp infective endocarditis following a prostate biopsy: a case report.
We report a rare case of an infective endocarditis by Aerococcus spp in a bioprosthetic aortic valve following a prostate biopsy, in an asymptomatic adult with no additional risk factor for prostate cancer, excepting for age. The diagnosi... | Recovered | ReactionOutcome | CC BY-NC | 33787738 | 19,225,298 | 2021 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Drug ineffective'. | Ebola Virus Transmission Initiated by Relapse of Systemic Ebola Virus Disease.
During the 2018-2020 Ebola virus disease (EVD) outbreak in North Kivu province in the Democratic Republic of Congo, EVD was diagnosed in a patient who had received the recombinant vesicular stomatitis virus-based vaccine expressing a ZEBOV g... | AMODIAQUINE\ARTESUNATE, AMOXICILLIN\CLAVULANATE POTASSIUM, CEFTRIAXONE, METRONIDAZOLE, OMEPRAZOLE, ONDANSETRON | DrugsGivenReaction | CC BY | 33789012 | 19,349,917 | 2021-04-01 |
What was the outcome of reaction 'Drug ineffective'? | Ebola Virus Transmission Initiated by Relapse of Systemic Ebola Virus Disease.
During the 2018-2020 Ebola virus disease (EVD) outbreak in North Kivu province in the Democratic Republic of Congo, EVD was diagnosed in a patient who had received the recombinant vesicular stomatitis virus-based vaccine expressing a ZEBOV g... | Fatal | ReactionOutcome | CC BY | 33789012 | 19,349,917 | 2021-04-01 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Altered state of consciousness'. | Evaluation of the Long-term Administration of Rifaximin for More than Three Years in the Treatment of Repeated and Recurrent Overt Hepatic Encephalopathy.
The patient was a 65-year-old man with alcoholic liver cirrhosis who had been admitted to hospital 5 times for repeated and recurrent overt hepatic encephalopathy (H... | ESOMEPRAZOLE MAGNESIUM, FUROSEMIDE, SPIRONOLACTONE | DrugsGivenReaction | CC BY-NC-ND | 33790139 | 19,201,911 | 2021 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Constipation'. | Evaluation of the Long-term Administration of Rifaximin for More than Three Years in the Treatment of Repeated and Recurrent Overt Hepatic Encephalopathy.
The patient was a 65-year-old man with alcoholic liver cirrhosis who had been admitted to hospital 5 times for repeated and recurrent overt hepatic encephalopathy (H... | ESOMEPRAZOLE MAGNESIUM, FUROSEMIDE, SPIRONOLACTONE | DrugsGivenReaction | CC BY-NC-ND | 33790139 | 19,201,911 | 2021 |
Subsets and Splits
No community queries yet
The top public SQL queries from the community will appear here once available.